ANN ARBOR, Mich. (PRWEB)
December 15, 2022

Cayman joins the Cayman Biomedical Research Institute (CABRI) in recognizing the ten undergraduate students who have been awarded fellowships by CABRI for the 2022-2023 academic year. The fellowship awards are given to talented undergraduates that are pursuing a research project of their own under the guidance of a faculty mentor.

Undergraduate fellowships are awarded by CABRI on a competitive basis each year to students who have been offered an unpaid research position. “These fellowships provide a valuable opportunity to undergraduates by allowing them to focus on gaining laboratory experience that builds their scientific talent,” said Kourtney Goode, Ph.D., Academic Relations Coordinator at Cayman.

CABRI funds expanded opportunities for emerging scientists and awards research grants to academic scientists that address basic science research objectives with the highest unmet needs. More information about CABRI’s undergraduate fellowships, scholarships, and research funding opportunities is available on the CABRI website – https://www.cabrimed.org/research/grants-and-scholarships/.

The 2022 Recipients Are:

Addison Thompson

Washington State University

Mentor: Ryan McLaughlin

Project: Using Rodent Models to Interrogate Effects of Cannabis Use During Pregnancy on the Postpartum Phenotype

Branwen Jorenby

Augsburg University

Mentor: Matthew Beckman

Project: Developing a CRISPR Design to Disrupt Hedgehog in Drosophila melanogaster

Caitlyn Bartsch

Southern Illinois University, Carbondale

Mentor: Jacob Nordman

Project: Synaptogenesis and Early Life Stress-Induced Aggression (ELSIA)

Christopher Polera

University of Central Florida

Mentor: Otto Phanstiel

Project: Reprogramming Pancreatic Tumors via FUBP1 Inhibition

Jeremy Nelson

University of Michigan

Mentor: Kenneth Kwan

Project: Cortical Alterations Following Deletion of Wiedemann-Steiner Syndrome Gene Kmt2a

Laura Clark

Virginia Commonwealth University

Mentor: Santiago Lima

Project: Role of Glycosphingolipids in Cell Migration and Invasion in Cancer

McKenna Spencer

Washington State University

Mentor: Ryan McLaughlin

Project: Cannabis Use in Females: Influence of Ovarian Hormones on Cannabis Vapor Self-Administration in Female Rats

Roman Voskoboynikov

Pennsylvania State University, Berks Campus

Mentor: Justin DiAngelo

Project: The Regulation of Lipid Transport and Metabolism by the Splicing Factor Glorund in the Drosophila Intestine

Stevie Rieger

Case Western Reserve University

Mentor: John Letterio

Project: Targeting Cathepsin B to Overcome Radiation Resistance in DIPG

Victoria Glass

University of South Carolina School of Medicine

Mentor: Claudia Grillo

Project: Identification of Hypothalamic Neurons Involved in a Novel Circuit that Regulates Feeding Behavior

About Cayman Chemical

Cayman Chemical Company (https://www.caymanchem.com/) helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, Cayman Contract Services provides discovery and preclinical development services to the global pharmaceutical, biotechnology, and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in medicinal chemistry, structure-based drug design, complex multi-step organic synthesis, analytical chemistry, sample analysis, and custom assay development. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.

About CABRI

Cayman Biomedical Research Institute (CABRI – https://www.cabrimed.org/) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or preclinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma) or B cell lymphoma.

Share article on social media or email: